Tailwinds are coming for cannabis stocks: Canaccord Genuity’s Bottomley
Matt Bottomley is a Canaccord Genuity analyst and joins “Squawk on the Street” to discuss Bottomley’s take on cannabis sector stocks, what to do if legislation fails, and more. For…
What Doctors are saying about CBD? | Cannabidiol
What are Doctors saying about CBD? | Cannabidiol You’ve heard of CBD, the cannabis product whose popularity has reached almost craze-like proportions. CBD has come from nowhere to everywhere in…